Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Summary

A 9-month randomized, double-blind, placebo-controlled study to compare the effect of fixed dose ferric citrate versus placebo in patients with advanced chronic kidney disease (eGFR ≤20 ml/min/1.73m2) on the composite endpoint of time to initiation of maintenance dialysis or all-cause mortality.

Timeline

Start

2022-03-30

Primary completion

2024-01-24

Completion

2024-01-24

Drugs

Indications